News
Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health:In patients with type 2 diabetes (T2D) not achieving glycemic targets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback